New implant targets prostate cancer locally before surgery
Disease control
Recruiting now
This early-phase study tests whether a small implant called Enolen can safely deliver the drug enzalutamide directly to prostate tumors in 56 men who are already scheduled for prostate removal surgery. The goal is to see if local drug delivery reduces side effects and controls th…
Phase: PHASE1 • Sponsor: Alessa Therapeutics Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC